First Trust Advisors LP lowered its position in Maximus Inc. (NYSE:MMS) by 22.4% during the second quarter, Holdings Channel reports. The firm owned 14,051 shares of the company’s stock after selling 4,058 shares during the period. First Trust Advisors LP’s holdings in Maximus were worth $778,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in MMS. Massmutual Trust Co. FSB ADV raised its stake in shares of Maximus by 3.6% in the first quarter. Massmutual Trust Co. FSB ADV now owns 3,879 shares of the company’s stock worth $204,000 after buying an additional 134 shares in the last quarter. Navellier & Associates Inc acquired a new position in shares of Maximus during the second quarter valued at about $208,000. Parametrica Management Ltd acquired a new position in shares of Maximus during the second quarter valued at about $216,000. LS Investment Advisors LLC raised its position in shares of Maximus by 70.9% in the second quarter. LS Investment Advisors LLC now owns 3,928 shares of the company’s stock valued at $217,000 after buying an additional 1,630 shares during the period. Finally, Capstone Asset Management Co. raised its position in shares of Maximus by 16.9% in the second quarter. Capstone Asset Management Co. now owns 7,262 shares of the company’s stock valued at $402,000 after buying an additional 1,050 shares during the period. Institutional investors and hedge funds own 99.00% of the company’s stock.
Shares of Maximus Inc. (NYSE:MMS) traded down 0.91% during mid-day trading on Friday, reaching $54.60. 468,431 shares of the company’s stock traded hands. The company has a 50 day moving average of $57.40 and a 200 day moving average of $55.79. Maximus Inc. has a 12 month low of $45.15 and a 12 month high of $69.85. The company has a market cap of $3.54 billion, a price-to-earnings ratio of 22.31 and a beta of 1.15.
Maximus (NYSE:MMS) last issued its earnings results on Thursday, August 4th. The company reported $0.75 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.04. Maximus had a return on equity of 23.89% and a net margin of 6.91%. The firm earned $617.10 million during the quarter, compared to the consensus estimate of $625.62 million. During the same quarter in the previous year, the firm earned $0.62 earnings per share. The business’s quarterly revenue was up 7.8% on a year-over-year basis. Analysts expect that Maximus Inc. will post $2.65 earnings per share for the current fiscal year.
Several research analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Maximus from a “hold” rating to a “sell” rating in a research note on Wednesday, August 3rd. KeyCorp assumed coverage on shares of Maximus in a research note on Monday, July 11th. They issued a “buy” rating on the stock. Finally, Maxim Group raised their target price on shares of Maximus from $71.00 to $74.00 and gave the company a “buy” rating in a research note on Thursday, August 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. Maximus presently has an average rating of “Buy” and an average price target of $63.00.
In related news, President Bruce Caswell sold 20,000 shares of the stock in a transaction that occurred on Thursday, September 22nd. The stock was sold at an average price of $56.99, for a total transaction of $1,139,800.00. Following the completion of the transaction, the president now directly owns 36,386 shares of the company’s stock, valued at $2,073,638.14. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Raymond B. Ruddy sold 18,000 shares of the stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $60.00, for a total value of $1,080,000.00. Following the transaction, the director now directly owns 295,552 shares of the company’s stock, valued at $17,733,120. The disclosure for this sale can be found here. 3.60% of the stock is owned by corporate insiders.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.